Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.100 AlteredExpression disease BEFREE Dual colour flow cytometry of p53 and c-erbB-2 expression related to DNA aneuploidy in primary and metastatic breast cancer. 1360329 1992
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.090 AlteredExpression disease BEFREE Dual colour flow cytometry of p53 and c-erbB-2 expression related to DNA aneuploidy in primary and metastatic breast cancer. 1360329 1992
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.060 AlteredExpression disease BEFREE All mucin markers which were investigated showed improved sensitivity for metastatic breast cancer compared with the established marker CEA. 2068512 1991
Entrez Id: 1084
Gene Symbol: CEACAM3
CEACAM3
0.040 AlteredExpression disease BEFREE All mucin markers which were investigated showed improved sensitivity for metastatic breast cancer compared with the established marker CEA. 2068512 1991
Entrez Id: 1087
Gene Symbol: CEACAM7
CEACAM7
0.040 AlteredExpression disease BEFREE All mucin markers which were investigated showed improved sensitivity for metastatic breast cancer compared with the established marker CEA. 2068512 1991
Entrez Id: 5670
Gene Symbol: PSG2
PSG2
0.040 AlteredExpression disease BEFREE All mucin markers which were investigated showed improved sensitivity for metastatic breast cancer compared with the established marker CEA. 2068512 1991
Entrez Id: 3880
Gene Symbol: KRT19
KRT19
0.100 Biomarker disease BEFREE Four of 19 patients with stage IV breast cancer had detectable K19 transcript in peripheral blood. 7509852 1994
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.100 Biomarker disease BEFREE Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer. 7526902 1994
Entrez Id: 23158
Gene Symbol: TBC1D9
TBC1D9
0.070 Biomarker disease BEFREE Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer. 7526902 1994
Entrez Id: 581
Gene Symbol: BAX
BAX
0.010 AlteredExpression disease BEFREE Bax protein levels were assessed by immunohistochemical methods in primary tumors derived from 119 women with metastatic breast cancer. 7671262 1995
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.100 Biomarker disease BEFREE Patients with ER+/c-erbB-2+ metastatic breast cancer are less likely to respond to hormone treatment than ER+/c-erbB-2- patients. 7738618 1995
Entrez Id: 2099
Gene Symbol: ESR1
ESR1
0.100 Biomarker disease BEFREE Decisions concerning the use of hormone therapy to treat metastatic breast cancer are made on the basis of the presence of estrogen receptor (ER). 7738618 1995
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.100 Biomarker disease BEFREE Reduced occurrence of mdr-1 amplification in stage-IV breast-cancer patients treated with tamoxifen compared with other endocrine treatments. 8094712 1993
Entrez Id: 23158
Gene Symbol: TBC1D9
TBC1D9
0.070 Biomarker disease BEFREE Reduced occurrence of mdr-1 amplification in stage-IV breast-cancer patients treated with tamoxifen compared with other endocrine treatments. 8094712 1993
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.030 Biomarker disease BEFREE In these studies, recombinant granulocyte colony stimulating factor (G-CSF) was administered to patients with metastatic breast cancer to increase the number of circulating stem cells. 8252190 1993
Entrez Id: 4830
Gene Symbol: NME1
NME1
0.010 AlteredExpression disease BEFREE Although nm23 expression seems diminished in metastatic breast cancer, it appears not to be the case in metastatic thyroid cancer. 8273382 1994
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.100 AlteredExpression disease BEFREE High tumor levels of ER, PgR, AR and pS2 predict a relatively good response to endocrine therapy, while EGF-R positively, HER2/neu positivity, aneuploidy, high proliferation indices and possibly high uPA levels indicate a high chance of poor response to endocrine therapy in metastatic breast cancer. 8481934 1993
Entrez Id: 1950
Gene Symbol: EGF
EGF
0.040 AlteredExpression disease BEFREE High tumor levels of ER, PgR, AR and pS2 predict a relatively good response to endocrine therapy, while EGF-R positively, HER2/neu positivity, aneuploidy, high proliferation indices and possibly high uPA levels indicate a high chance of poor response to endocrine therapy in metastatic breast cancer. 8481934 1993
Entrez Id: 2099
Gene Symbol: ESR1
ESR1
0.100 GeneticVariation disease BEFREE An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer. 9102207 1997
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.010 AlteredExpression disease BEFREE GST activity was significantly higher in EBC than in LABC or metastatic breast cancer (P = 0.02). 9209662 1997
Entrez Id: 373156
Gene Symbol: GSTK1
GSTK1
0.010 AlteredExpression disease BEFREE GST activity was significantly higher in EBC than in LABC or metastatic breast cancer (P = 0.02). 9209662 1997
Entrez Id: 283871
Gene Symbol: PGP
PGP
0.010 Biomarker disease BEFREE Due to its high prevalence (83% in EBC, 100% in primarily metastatic breast cancer), PGP did not add to prognostic information. 9209662 1997
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.100 Biomarker disease BEFREE Overexpression of c-erbB-2 protein, the cut-off value being set at 18 ng/mg protein, was observed in 26 of the 139 cases of stages I-IIIB breast cancer (18.7%), four of the 12 cases of stage IV breast cancer (33.3%) and seven of the 13 recurrent breast cancer cases (53.8%). 9544822 1998
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.010 GeneticVariation disease BEFREE Vitamin D receptor gene polymorphism is associated with metastatic breast cancer. 9613456 1998
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.030 AlteredExpression disease BEFREE IGF-receptor expression in cancer tissues and metastatic breast cancer cells supports the hypothesis that IGFs increase tumor cell proliferation in vivo. 9615787 1998